ASSOCIATION FOR MOLECULAR PATHOLOGY v. MYRIAD GENETICS, INC.: PROGRESS BY PRINCIPLES.

The article offer information on the judicial decision of the U.S. Supreme Court in the case of Association for Molecular Pathology v. Myriad Genetics Inc., in which the Court addressed the patentability issues related to human genes under the Patent Act of 1952. Topics discussed include the legal suit against the U.S. Patent and Trademark Office (PTO) related to genetic testing services, laws for analysis of DNA sequences, and Mayo Collaborative Services v. Prometheus Laboratories Inc. case.